Retour
Fourchette du Jour
153,46 €
159,40 €
Fourchette 52 Semaines
86,99 €
191,50 €
Volume
378 201
Moyenne 50J / 200J
174,32 €
/
137,24 €
Clôture Précédente
156,92 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -43,8 | 0,4 |
| P/B | 90,9 | 2,9 |
| ROE % | -252,1 | 3,8 |
| Net Margin % | -28,7 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 2,7 | 0,2 |
Points Clés
Debt/Equity of 2,73 — high leverage
Negative free cash flow of -93,41M
Capital efficient — spends only 0,00% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)65,55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-252,11%
ROIC-38,51%
Net Margin-28,69%
Op. Margin-26,51%
Sécurité
Debt / Equity
2,73
Current Ratio1,55
Interest Coverage-25,81
Valorisation
P/E Ratio
-43,80
P/B Ratio90,86
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 65,55% | Revenue Growth (3Y) | 53,61% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 638,50M | Net Income (TTM) | -183,17M |
| ROE | -252,11% | ROA | -26,55% |
| Gross Margin | 92,56% | Operating Margin | -26,51% |
| Net Margin | -28,69% | Free Cash Flow (TTM) | -93,41M |
| ROIC | -38,51% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,73 | Current Ratio | 1,55 |
| Interest Coverage | -25,81 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -43,80 | P/B Ratio | 90,86 |
| P/S Ratio | 12,57 | PEG Ratio | 1,29 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 8,02B | Enterprise Value | 7,94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 638,50M | 385,69M | 270,60M | 50,04M | 0,0 |
| Net Income | -183,17M | -287,22M | -239,24M | -187,13M | -130,40M |
| EPS (Diluted) | -3,68 | -5,99 | -5,27 | -4,60 | -3,47 |
| Gross Profit | 591,02M | 352,39M | 244,54M | 44,84M | 0,0 |
| Operating Income | -169,24M | -280,56M | -231,83M | -179,80M | -124,71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 689,81M | 568,50M | 588,24M | 331,48M | 87,79M |
| Total Liabilities | 601,51M | 511,48M | 397,26M | 221,92M | 72,15M |
| Shareholders' Equity | 88,30M | 57,02M | 190,98M | 109,56M | 15,63M |
| Total Debt | 241,30M | 192,96M | 186,37M | 94,68M | 49,71M |
| Cash & Equivalents | 322,93M | 315,35M | 386,19M | 200,84M | 86,47M |
| Current Assets | 588,99M | 485,06M | 504,26M | 245,64M | 86,52M |
| Current Liabilities | 378,84M | 230,10M | 138,85M | 96,56M | 23,07M |